GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.867 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.1759 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7, OPRD1, OPRK1, OPRM1 |
8.93876 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR5A, HTR7, OPRD1, OPRK1, OPRM1 |
8.46006 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, AXL, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP4, FLT3, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
8.46006 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7, OPRD1, OPRK1, OPRM1 |
8.46006 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, AXL, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP4, FLT3, HTR5A, IGF1R, KDR, MMP2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
8.36996 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, HTR5A, IGF1R, MMP2, MMP9, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
8.27146 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, DRD1, DRD2, DRD3, ESR1, F2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, SIGMAR1, SRC |
8.23741 |
[BP] GO:0007200 |
None
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B, OPRD1, OPRK1, OPRM1 |
8.02974 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, HTR5A, OPRK1, OPRM1, PDE3A, SRC |
8.02974 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F2, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, OPRK1, OPRM1, SRC, XDH |
7.84683 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F2, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, OPRK1, OPRM1, SRC, XDH |
7.84019 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F2, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
7.79308 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HTR2B, PDE10A, PDE3A, PDE3B, PIM1, XDH |
7.56761 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, ESR1, F2, F3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR7, KDR, MET, OPRD1, OPRK1, OPRM1, PDE3A, SRC, XDH |
7.52026 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, F2, HTR2A, HTR2B, KDR, SRC |
7.3782 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, OPRM1, PIM1, SRC, XDH |
7.2363 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.19127 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.19127 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, CA3, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, OPRK1, OPRM1, PDE3A, SRC |
7.18648 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FLT3, HTR5A, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
7.07875 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
6.82755 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
6.69534 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CA3, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, OPRD1, OPRK1, SRC |
6.68739 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, SIGMAR1, SRC |
6.58447 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3 |
6.50652 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, AXL, CYP1B1, DRD2, F2, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, OPRK1, OPRM1, SRC, XDH |
6.30097 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, SRC, XDH |
6.16604 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PDE3A, SRC |
6.16604 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.9886 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, ALOX5, ALPL, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F2, F3, FABP4, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, SRC |
5.97253 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, DRD3, F2, HTR2A, HTR2B, KDR, OPRK1, SRC |
5.9118 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A, OPRK1 |
5.79056 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F2, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP9, OPRK1, OPRM1, SRC, XDH |
5.67973 |
[BP] GO:0038003 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.63559 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HSD17B1, HTR1A, HTR2A, OPRK1 |
5.59292 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.48387 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, AURKB, AXL, CA2, CA3, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F2, F3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
5.33098 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, DRD2, DRD3, ESR1, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1 |
5.30923 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3 |
5.28927 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A, OPRM1, PDE3A |
5.28866 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FLT3, HTR5A, OPRK1, PDE3B, SRC |
5.24449 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PDE3A, SRC |
5.24449 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, SRC, XDH |
5.15351 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
5.15351 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F2, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP2, MMP9, OPRK1, OPRM1, SRC, XDH |
5.0886 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.04022 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A, OPRM1, PDE3A |
5.04022 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
5.00653 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.8252 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
4.82328 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.82108 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FLT3, HTR5A, OPRK1, OPRM1, SRC |
4.81417 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, F2, HTR1A, HTR2A, MMP9, OPRD1, OPRK1, OPRM1 |
4.79746 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR, OPRM1, PDE3A |
4.79506 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, HSD17B1 |
4.61973 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, HTR2A, HTR2B, OPRM1 |
4.60124 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.51934 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
4.46737 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.46134 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.46134 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F2, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP2, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
4.42671 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A, OPRK1 |
4.42502 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, FLT3, HSD17B1, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, SENP6, SRC, XDH |
4.40441 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, ESR1, FABP4, HSD17B1, MET, PDE3A |
4.36576 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, FABP4, FLT3, HTR2A, HTR2B, MET, SRC |
4.36222 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MET, MMP9, PDE3A, PIM1, SIGMAR1, SRC, XDH |
4.36179 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.30957 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, SRC, XDH |
4.30366 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.29531 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
4.28237 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F2, F3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, SRC |
4.26775 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, AXL, CA2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F2, F3, HTR2A, HTR2B, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, SRC, XDH |
4.19386 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, ESR1, HTR7, OPRK1, OPRM1, SRC |
4.19386 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, DRD1, DRD2, ESRRB, F2, FLT3, HTR2A, HTR2B, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
4.19386 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, DRD1, DRD2, ESRRB, F2, FLT3, HTR2A, HTR2B, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
4.19386 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, DRD3, HTR2A, OPRD1, OPRK1, OPRM1 |
4.1746 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, FLT3, HSD17B1, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, PDE10A, PDE3A, PDE3B, PIM1, SENP6, SRC, XDH |
4.17372 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESR2, F2, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
4.1681 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, OPRD1, OPRK1, OPRM1 |
4.1194 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, OPRD1, OPRK1, OPRM1 |
4.1194 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET, OPRK1 |
4.1011 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP9, OPRK1, OPRM1, PDE3B, SRC, XDH |
4.06372 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, DRD2, ESRRB, F2, FLT3, HTR2A, HTR2B, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
4.06305 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP9, OPRK1, OPRM1, PDE3B, SRC, XDH |
4.05426 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, OPRD1, OPRK1, OPRM1 |
4.05426 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, OPRD1, OPRK1, OPRM1 |
4.05426 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.03683 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.03683 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, HTR2A, HTR2B, MMP2, OPRD1, OPRK1, OPRM1, SRC |
4.00637 |
[BP] GO:0072523 |
None
|
AOX1, PDE10A, PDE3A, PDE3B, XDH |
4.00547 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.97158 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.97158 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MET, MMP9, PDE3A, PIM1, SIGMAR1, SRC, XDH |
3.96702 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, FLT3, HTR2A, HTR2B, KDR, OPRK1, OPRM1, SRC, XDH |
3.94522 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, OPRD1, OPRK1, OPRM1 |
3.93952 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP4, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, SRC, XDH |
3.89573 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, IGF1R, KDR, MET, MMP9, OPRK1, SRC |
3.88618 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, DRD1, DRD2, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.84902 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MMP9, PDE3A, PIM1, SIGMAR1, SRC, XDH |
3.84792 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3 |
3.82462 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AURKB, AXL, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PDE3A, PDE3B, PIM1, SIGMAR1, SRC |
3.81703 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.76101 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, AXL, CA2, CYP1B1, DRD2, DRD3, ESRRB, F2, F3, HTR2A, HTR2B, KDR, MET, MMP9, OPRM1, PDE3A, PIM1, SRC |
3.74013 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, PDE3A |
3.70612 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, DRD1, DRD2, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.70602 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.62564 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, FABP4, HTR2A, HTR2B, MET |
3.61433 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, DRD2, F2, FLT3, HTR2A, HTR2B, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.60645 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.58706 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.58706 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.58706 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, OPRM1, PDE3A, SRC |
3.56345 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A, OPRK1 |
3.55775 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.54319 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
3.54211 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, AURKB, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.54168 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, OPRD1, OPRK1, OPRM1 |
3.51358 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.49983 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, F2, FLT3, HTR2A, HTR2B, PDE3B, SRC |
3.46296 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2 |
3.44195 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, SENP6, SIGMAR1, SRC, XDH |
3.44195 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, OPRK1, OPRM1, SRC, XDH |
3.40392 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.40392 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, PDE3A |
3.37265 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.36295 |
[BP] GO:0043278 |
None
|
DRD2, DRD3, OPRK1, OPRM1 |
3.36232 |
[BP] GO:0014072 |
None
|
DRD2, DRD3, OPRK1, OPRM1 |
3.36232 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, HTR2A, HTR2B, KDR, OPRM1, SRC |
3.35839 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3, OPRM1 |
3.3399 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, SRC, XDH |
3.3399 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AXL, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, OPRD1, OPRK1, OPRM1 |
3.3399 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PDE3A, PIM1, SRC |
3.3399 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, OPRM1, PIM1, SRC |
3.33167 |
[BP] GO:0007191 |
None
|
DRD1, DRD3, OPRM1 |
3.33167 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.33167 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.33167 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
3.28777 |
[BP] GO:0051930 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.28777 |
[BP] GO:0051931 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.28777 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, AURKB, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.27126 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, OPRK1, PDE3A, PDE3B, SRC |
3.24303 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.24303 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.21431 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
3.20794 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A |
3.20676 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F3, MET, SRC, XDH |
3.20676 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.20422 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, ESR1, IGF1R, MET, MMP9, PDE3B, SRC, XDH |
3.16495 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, OPRM1 |
3.16222 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
3.1545 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
3.14932 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, CYP1B1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR7, OPRD1, OPRK1, OPRM1, PDE3A, SRC |
3.13052 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
3.11685 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, MMP9, OPRD1, OPRM1, PIM1, SRC, XDH |
3.10711 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, ESR1, F2, F3, FABP4, KDR, MET, OPRM1 |
3.10528 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, HTR1A |
3.10431 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, F2 |
3.04187 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.02071 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
3.02071 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, CA3, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, SRC, XDH |
3.0099 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
3.00817 |
[BP] GO:0060359 |
None
|
DRD1, DRD2, DRD3, OPRK1, OPRM1 |
2.99296 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PDE3A, PIM1, SRC |
2.99168 |
[BP] GO:0031635 |
None
|
OPRK1, OPRM1 |
2.98257 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.98257 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, F2, FLT3, HTR5A, KDR, MMP9, PIM1, SIGMAR1, SRC |
2.95819 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, OPRK1, OPRM1, SRC |
2.95819 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, CSNK2A1, DRD2, ESR1, F2, F3, FLT3, HTR2A, HTR2B, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.95819 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.95819 |
[BP] GO:0006195 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.95819 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.95819 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FLT3, HTR2A, HTR2B, SRC |
2.95819 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.95819 |
[BP] GO:0006198 |
None
|
PDE10A, PDE3A, PDE3B |
2.95819 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.95819 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.95819 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
2.95412 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
2.94542 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
2.89405 |
[BP] GO:0007631 |
None
|
DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
2.8752 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.8752 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.87203 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP3A4, PDE10A, PDE3A, PDE3B, XDH |
2.85273 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, F2, HTR2A, HTR2B |
2.84587 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.84174 |
[BP] GO:0050433 |
None
|
DRD2, DRD3, HTR2A, OPRK1 |
2.83208 |
[BP] GO:0043266 |
None
|
ADORA1, DRD1, DRD2, HTR2A, OPRK1 |
2.82365 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
2.82137 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, F2, HTR1A, HTR2A, HTR2B, MMP9, OPRD1, OPRK1, OPRM1, SRC |
2.80872 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MMP9, PDE3A, PIM1, SRC |
2.80759 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.80731 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.80731 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, CA3, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, SRC, XDH |
2.80004 |
[BP] GO:0010959 |
None
|
ADORA1, DRD1, DRD2, DRD3, F2, HTR2A, OPRD1, OPRK1 |
2.78028 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.78028 |
[BP] GO:0009214 |
None
|
PDE10A, PDE3A, PDE3B |
2.73595 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, SRC |
2.72429 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.72429 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, OPRK1, OPRM1, SRC |
2.72219 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, KDR, SRC |
2.72219 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, OPRM1, PDE3A, SRC |
2.72125 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.71055 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, DRD2, ESR1, F2, F3, FLT3, HTR2A, HTR2B, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.71055 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, F2, F3, FLT3, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, SENP6, SRC, XDH |
2.69922 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, AURKB, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.69783 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, AURKB, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MMP9, OPRM1, SRC, XDH |
2.68625 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DRD2, F2, OPRM1 |
2.68625 |
[BP] GO:0007626 |
None
|
DRD1, DRD2, DRD3, OPRD1, OPRK1, OPRM1 |
2.68625 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.67913 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.66628 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
2.65981 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, DRD2, F2, FLT3, HTR2A, HTR2B, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.65646 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.64587 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, HTR2A, HTR2B, KDR, OPRM1, SRC |
2.62817 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.6238 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.6238 |
[BP] GO:0009187 |
None
|
HTR2B, PDE10A, PDE3A, PDE3B |
2.6238 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.6238 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.6238 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.6238 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.6238 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.62061 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
2.618 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
2.61636 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HTR2B, OPRK1, SRC |
2.61291 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, F2, HTR2A, HTR2B, MMP9, OPRD1, OPRM1, SIGMAR1, SRC, XDH |
2.61095 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, F2, HTR2A, HTR2B |
2.6036 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
2.6036 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.59207 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
2.58834 |
[BP] GO:0072347 |
None
|
DRD2, DRD3, OPRK1, OPRM1 |
2.58275 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, OPRM1, SRC |
2.58009 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.58009 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, DRD1, DRD2, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.57883 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, F2, HTR2A, HTR2B |
2.55674 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
2.54452 |
[BP] GO:1904062 |
None
|
DRD1, DRD2, DRD3, F2, MMP9, OPRK1, OPRM1 |
2.54055 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.54055 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.54055 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.54055 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.53742 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.53118 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.53118 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
2.5184 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, DRD2, DRD3, HTR2A, OPRD1, OPRK1, OPRM1 |
2.51205 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B, MMP9, OPRD1, OPRM1, SIGMAR1, SRC, XDH |
2.51174 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, OPRD1 |
2.5099 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, DRD2, F2, F3, MET, OPRK1, XDH |
2.50856 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1 |
2.49611 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
2.49611 |
[BP] GO:0042698 |
ovulation cycle
|
AXL, OPRK1, OPRM1 |
2.48223 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.48223 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
2.48031 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.47593 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FLT3, HTR2A, HTR2B, SRC |
2.47083 |
[BP] GO:0009166 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.45117 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.43056 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.43056 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.42818 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, F2, HTR2B, OPRK1, SRC |
2.42098 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, FABP4, MET, PDE3A |
2.41796 |
[BP] GO:0007610 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, OPRD1, OPRK1, OPRM1 |
2.40323 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
2.39728 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.39728 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.39728 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.39728 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.39426 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.39426 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.39426 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.38222 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, F2, IGF1R, MET, MMP9, PDE3B, SRC, XDH |
2.37208 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, SENP6, SIGMAR1, SRC, XDH |
2.37085 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, DRD1, ESR1, FLT3, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.37085 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.36471 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.34669 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, F2, HTR2B, HTR6, KDR, MMP1, MMP9, SRC |
2.339 |
[BP] GO:1901292 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.33032 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, F2, HTR2A, HTR2B, MMP9, OPRD1, OPRM1, SIGMAR1, SRC, XDH |
2.31289 |
[BP] GO:0031644 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
2.30827 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.30485 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.30485 |
[BP] GO:0008306 |
None
|
DRD1, DRD2, DRD3, OPRK1 |
2.28902 |
[BP] GO:0034762 |
None
|
CA2, DRD1, DRD2, DRD3, F2, MMP9, OPRK1, OPRM1 |
2.28097 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FLT3, HTR2A, HTR2B, SRC |
2.26766 |
[BP] GO:0045745 |
None
|
DRD2, DRD3, F2 |
2.25953 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, HTR2A, MMP9 |
2.23718 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, MMP2, MMP9, OPRK1, OPRM1, PDE3A, SRC |
2.2329 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP4, PDE10A, PDE3A, PDE3B, SRC, XDH |
2.2329 |
[BP] GO:0042755 |
None
|
OPRD1, OPRK1, OPRM1 |
2.22236 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.22236 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.22236 |
[BP] GO:0051302 |
None
|
AURKB, DRD2, DRD3, ESRRB, HTR2B |
2.22236 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, F2, HTR2B, HTR6, KDR, MET, MMP1, MMP9, SRC |
2.22236 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.22236 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.22236 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.22236 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.22236 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.22236 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.22236 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, HTR2B, SRC |
2.2128 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.19828 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP4, PDE10A, PDE3A, PDE3B, XDH |
2.19482 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, OPRM1 |
2.19044 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, AURKB, DRD2, ESR1, ESR2, F2, F3, FLT3, HTR2A, HTR2B, MET, MMP9, OPRD1, SRC, XDH |
2.19028 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, OPRK1, OPRM1 |
2.19028 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, CA1, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, SENP6, SIGMAR1, SRC, XDH |
2.18929 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, F2, FLT3, IGF1R, KDR, MET, SENP6, SRC |
2.18555 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3 |
2.1841 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, CYP19A1, ESR1 |
2.15252 |
[BP] GO:0009154 |
None
|
PDE10A, PDE3A, PDE3B |
2.15252 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3 |
2.14525 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, OPRM1 |
2.13171 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HSD17B1, XDH |
2.11923 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, OPRM1 |
2.11923 |
[BP] GO:0009261 |
None
|
PDE10A, PDE3A, PDE3B |
2.11923 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R |
2.11923 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.11923 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.0861 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, OPRM1 |
2.08247 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, HTR6 |
2.08247 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.08247 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.08247 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.08247 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.08247 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.08247 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.08247 |
[BP] GO:0051781 |
None
|
AURKB, DRD2, DRD3, HTR2B |
2.06357 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
F2, FLT3, SRC |
2.05208 |
[BP] GO:0046058 |
None
|
PDE10A, PDE3A, PDE3B |
2.05208 |
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.04745 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, F2, HTR2B, HTR6, KDR, MMP1, MMP9, SRC |
2.04745 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, ESR1, F2, HTR2A, HTR2B |
2.04578 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, OPRD1, SIGMAR1 |
2.04526 |
[BP] GO:0040017 |
positive regulation of locomotion
|
DRD1, F3, IGF1R, KDR, MET, MMP9, OPRK1, SRC |
2.0296 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A |
2.02735 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, OPRM1 |
2.02027 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.01876 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
2.0007 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CA4, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
7.31757 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
6.19299 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, AXL, CA2, CA4, CA9, DRD1, DRD2, DRD3, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
5.29519 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PIM1, SRC |
4.74471 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SIGMAR1, SRC |
3.36367 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3B, PIM1, SIGMAR1, SRC |
3.3589 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, OPRD1, OPRM1, SRC |
3.06781 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, DRD1, DRD2, HTR2A, MET, OPRD1, OPRM1, SIGMAR1, SRC |
2.90092 |
[CC] GO:0043204 |
None
|
DRD2, HTR5A, OPRK1, OPRM1, PDE10A |
2.57883 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA4, CA9, CYP3A4, DRD1, DRD2, DRD3, ESR1, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SIGMAR1 |
2.30642 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, HTR6, OPRD1, OPRK1, OPRM1, SRC |
2.16564 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, CA4, CA9, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
2.11923 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, CA4, CA9, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
2.11923 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
20.2845 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, XDH |
13.3382 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, SRC, XDH |
13.2164 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.1628 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.6391 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
11.0537 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, XDH |
11.0537 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
9.847 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
9.55642 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
8.93876 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
8.52966 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, OPRM1 |
8.5078 |
[MF] GO:0008227 |
None
|
ADRA1A, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.97126 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
7.84019 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
7.73355 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
7.73355 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, OPRM1 |
7.64213 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
7.25863 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.19127 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.19127 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.15068 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.15068 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
7.01031 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9 |
6.60679 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, F2, F3, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, SENP6, SRC, XDH |
6.38986 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PDE10A, PIM1, SIGMAR1, SRC |
6.15158 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, XDH |
6.05914 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
5.63559 |
[MF] GO:0004985 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.63559 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.38806 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F2, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, XDH |
5.38543 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
5.2988 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC |
4.38423 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC |
4.19797 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
4.17372 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
3.97158 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.59533 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.44195 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HSD17B1, SRC, XDH |
3.36295 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2D6, CYP3A4 |
3.28777 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.18514 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.11685 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
3.02071 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.98257 |
[MF] GO:0004119 |
None
|
PDE3A, PDE3B |
2.98257 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
2.95819 |
[MF] GO:0047555 |
None
|
PDE10A, PDE3A, PDE3B |
2.95819 |
[MF] GO:0004115 |
None
|
PDE10A, PDE3A, PDE3B |
2.8752 |
[MF] GO:0005488 |
binding
|
ACHE, ADORA1, ADRA1A, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, SENP6, SIGMAR1, SRC, XDH |
2.82137 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.78028 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.78028 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HSD17B1, XDH |
2.7427 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.66628 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.66547 |
[MF] GO:0001965 |
None
|
HTR2A, HTR2B, OPRM1 |
2.6238 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.6238 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.58009 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.54055 |
[MF] GO:0042923 |
None
|
OPRD1, OPRK1, OPRM1 |
2.48223 |
[MF] GO:0008289 |
lipid binding
|
AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, HSD17B1 |
2.39728 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.39728 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.39728 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.39728 |
[MF] GO:0004114 |
None
|
PDE10A, PDE3A, PDE3B |
2.39426 |
[MF] GO:0004112 |
None
|
PDE10A, PDE3A, PDE3B |
2.34727 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.22236 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.22236 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.08247 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.08247 |